ForePass outperforms Semaglutide in weight control, glucose metabolism, and gut microbiota in swine.

Diabetes Obes Metab · 2025 · PMC12587247 · PMID 41025205

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

This represents a highly significant reduction of weight gain compared with sham and Semaglutide, highlighting the superior effect of ForePass in suppressing excess weight accumulation during a period of active growth.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.